Slimy Liquid CBD Reviews (2023)– Does It Really Helps With Weight Loss?

Slimy Liquid CBD Reviews
Slimy Liquid CBD Reviews

Are you looking for Slimy Liquid CBD Reviews? Read further to know more. If you are interested in holistic healthcare, then you may already know about CBD-based medications as well as their physical and mental benefits. Nowadays, more and more people are shifting from conventional medications to CBD-infused alternatives. 

It has several amazing benefits for your health, especially if you’re trying to lose weight and get an even skin tone. However, as CBD-based products are getting popular, numerous options are now available in the market for you to choose from.

This makes it quite hard to choose the one that fits the bill for you. Today, we’re going to talk about one of the most popular CBD-based products out there – the Slimy Liquid CBD drops. The product is touted a lot for its facilitation of weight loss. 

Let’s take a look at what these CBD drops consist of and how they can help you achieve your desired body shape. We’ll also be discussing certain important things such as its benefits, side effects, and more. So, make sure that you read on! 

What Is Slimy Liquid CBD Drops?

Slimy Liquid CBD Reviews
  • Relieving aches and pain
  • Decreased Inflammation
  • Improved Sleep Quality
  • Better mood and joint health
  • Lower Sugar Levels Less Stress

Slimy Liquid CBD drops are cannabis-based consumables designed to help you lose weight quickly and effectively. The results are permanent, thanks to the various natural ingredients available in it. 

It features a unique composition that promotes certain processes in your body required for weight loss such as curtailing your appetite and suppressing your cravings. It also works towards optimizing your body’s fat-burning capability. 

The drops even increase your body’s energy consumption, which is why the product is considered a highly versatile solution for effective weight loss. Apart from weight loss, there are even several positive effects of these CBD drops on your general well-being. 

Moreover, unlike other slimming products, Slimy Liquid CBD is available in form of droplets that boost your metabolism levels when consumed. Keep in mind that it doesn’t work as a meal replacement and you can keep taking your regular diet. 

Components Of Slimy Liquid CBD Drops

The Slimy CBD Drops primarily consist of cannabidiol and hemp extracts that are known to build ECS neuromodulatory lipids to promote better functioning of cardiovascular, nervous, and immune system processes. 

It also consists of several other ingredients that facilitate weight loss such as: 

Eucalyptus Extract

Every single drop of our Slimy Liquid CBD Drops contains the natural compound Eucalyptus Extract, which is primarily used to help reduce inflammation in the body.

Eucalyptus is a powerful anti-inflammatory that works to heal your body and help you recover from injuries. It also has amazing muscle-strengthening properties that can help you build stronger muscles and reduce joint pain.

Clove Oil

Clove oil is a natural product that has been used for centuries to treat skin ailments and pain. The main active ingredient in clove oil is eugenol, which has anti-inflammatory and anti-bacterial properties. 

Eugenol also helps to fight infections, so it’s an excellent choice for people with coughs or colds. It can also help you lose weight by improving your metabolic rate and increasing your energy levels.

Ginger Extract

Ginger extract is rich in antioxidants and has antibacterial properties. It improves your immune system, which is great for those who do a lot of physical activity or those with a tendency toward getting sick. It can also be used to treat pain conditions, including joint pain, muscle aches, and headaches.

Coconut Oil

Coconut Oil is a natural remedy for migraines. It can also be used to treat pains and inflammation of the joints and improve the overall health of the body. It also contains lauric acid and caprylic acid. 

These acids are able to reduce oxidative stress and inflammation in the body. This component also has antibacterial properties that help fight off infection in the body. It can also help improve your skin’s condition by reducing wrinkles and blemishes.

Who Should Consume Slimy Liquid CBD Drops?

Slimy Liquid CBD Reviews
Slimy Liquid CBD Reviews

If you’re looking for a way to improve your mental fitness and wellness, then you might want to give Slimy Liquid CBD drops a try. Slimy Liquid CBD drops are meant to be consumed by adults over 18 years old. 

They will help build a better foundation for your health, helping you feel great and live a happier life. If you’re underage, don’t try these! The product is designed to make you feel great—and it won’t work if you take it without being over 18 years old!

People who have a sore lifestyle are the ideal audience for this product because they’re looking for something that can reduce their pain and inflammation. This can make them feel more comfortable in their everyday lives, so they can get back on track with their health goals.

Benefits of Slimy Liquid CBD Drops

Here’s a list of the various benefits that the Slimy Liquid CBD drops offer: 

Excessive Fat Reduction

The Slimy Liquid CBD Drops are incredibly effective for reducing excessive fat. This product is made with a unique blend of ingredients that help to boost the metabolism and support weight loss by helping to burn fat more quickly. 

The Slimy Liquid CBD Drops also contain ingredients that have been shown to help maintain your energy levels throughout the day, so you can feel energized without being tired. 

Finally, the Slimy Liquid CBD Drops contain cannabidiol (CBD), which is one of the most well-known ingredients in cannabis and has been shown to reduce inflammation and pain caused by diseases such as fibromyalgia or arthritis.

Texture Improvement

If you’re looking for a way to improve your body’s texture, Slimy Liquid CBD Drops are the answer. These drops are made using a combination of hemp and several different types of oils, which are then infused with CBD. 

These drops are designed to reduce inflammation and help your skin retain moisture, making it feel softer and more supple. They can help to reduce inflammation, increase circulation, and promote the growth of collagen in your skin.

Body Tone Enhancement

The slimy liquid CBD drops are designed to help you achieve a leaner, more toned physique. However, it is important to note that this slimy liquid CBD drops only work when combined with exercise and diet.

Some people may experience some minor side effects from using the slimy liquid CBD drops such as dry mouth or lightheadedness but these are usually temporary and should go away after taking some time off from using the product.

When used properly, Slimy Liquid CBD Drops can help you achieve a slimmer waistline and improved muscle tone in quite less time. 

Stress Reduction

CBD oil is a natural supplement that can help reduce stress, anxiety, and depression in people who have difficulty sleeping. If you’re looking for an alternative to prescription medication for treating your sleep disorder, then using these CBD drops is a great choice.

The main benefit of using CBD drops is that they don’t contain any THC, which means they won’t make you high or cause you to feel groggy after taking them. This makes them ideal for people who want to use CBD without feeling any side effects (which can include nausea or vomiting).

These CBD drops also work quickly, so they can be used as soon as they arrive at your door. You can easily pop one or two into your mouth during the day and let them do their work while you focus on other things.

Minimal Side Effects

Slimy Liquid CBD Drops are a great option for anyone looking for a natural, non-psychoactive solution for pain management and weight loss.

They’re infused with CBD, which means that it doesn’t have any psychoactive effects. This makes it ideal for patients who suffer from anxiety, depression, or other conditions that may cause them to feel anxious or depressed.

The slimy liquid is also easy on the stomach—it has no artificial ingredients. This makes Slimy Liquid CBD Drops an excellent choice for people who have trouble sleeping because they can take them during the day without any side effects.

How To Use Slimy Liquid CBD Drops Properly?

There are a few basic steps that you need to follow in order to get solid results from Slimy Liquid CBD Drops.

First, you’ll want to make sure that this product fits into your lifestyle. You should only use the oil as directed by your body type. There’s no compelling reason to increase the grooming of your body. Try to use 5-6 drops of oil at first and then work your way up from there as needed.

Second, you’re going to need to keep the oil under your tongue for about 30 seconds before swallowing it down so that it has enough time to coat your throat and stomach lining with fatty acids and other compounds that will help support digestion and absorption.

Third, if possible, try taking it with meals or snacks so that it gets into your bloodstream faster and has more time to do its job!

Recommended Dosage for Slimy Liquid CBD Drops

The Slimy Liquid CBD Drops can be taken as is, or with food. Here are some things to keep in mind:

  • Take 20 drops per day. The best way to take these drops is by placing them under your tongue, then waiting 60 seconds before swallowing them.
  • Don’t dilute the liquid: it must be taken purely for maximum effect.
  • Don’t take more than two capsules at any one time, as the effects may not last long enough to justify overdoing it!

How Much Does Slimy Liquid CBD Drop Cost?

Slimy Liquid CBD reviews
Slimy Liquid CBD reviews

The price of CBD tinctures is subject to change, and the cost can vary widely depending on the product and the quantity you purchase.

We make it easy for you to find the best deal on slimy liquid CBD drops by offering a variety of options for purchasing your CBD products. 

The demand for this kind of product is huge, so it’s not surprising that when something gets popular and people want it, the price goes up.

Are There Any Side Effects of Slimy Liquid CBD Drops?

If you’re thinking about using CBD, you’ve probably heard the same thing over and over: “It’s not addictive.” But can it have any side effects? The answer is yes! But the good news is, that Slimy Liquid CBD Tincture doesn’t cause any serious problems.

As with any medication, there are some possible side effects of using CBD—but these are usually minor and manageable if you take care of yourself.

For example, some people experience dry mouth or a change in taste sensations when they use this product. Others may experience headaches or fatigue. Allergic reactions are also possible, but they’re rare.

Before ordering, we recommend consulting with your doctor about how to use this product safely for the best results.

Where to Buy Slimy Liquid CBD Drops?

If you’re still thinking about where to buy this supplement, we have two options for you. First, you can try to find the official website on your own. Or, if that’s too much work, click on the link on this page to quickly get access to the best-selling supplement. 

It will send you directly to the product page so you can see which exclusive offers are accessible.

Final Words

The bottom line is that if you’re looking to drop some weight, Slimy Liquid CBD Drops could be a worthwhile addition to your journey.

The convenience factor alone makes it worth giving it a shot, especially since there are no negative side effects associated with its use. Give it a shot for yourself and see if it can help kick-start your own weight loss journey.

[1]
1. Berman, P., Futoran, K., Lewitus, G. M., Mukha, D., Benami, M., Shlomi, T., et al. (2018). A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. Sci. Rep. 8:14280. doi: 10.1038/s41598-018-32651-4
PubMed Abstract | CrossRef Full Text | Google Scholar

2. Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., et al. (2013). Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br. J. Pharmacol. 168, 1456–1470. doi: 10.1111/bph.12043
PubMed Abstract | CrossRef Full Text | Google Scholar

3. Bosy, T. Z., and Cole, K. A. (2000). Consumption and quantitation of Δ9-tetrahydrocannabinol in commercially available hemp seed oil products. J. Anal. Toxicol. 24, 562–566. doi: 10.1093/jat/24.7.562
CrossRef Full Text | Google Scholar

4. Callaway, J. C. (2004). Hempseed as a nutritional resource: an overview. Euphytica 140, 65–72. doi: 10.1007/s10681-004-4811-6
PubMed Abstract | CrossRef Full Text | Google Scholar

5. Callaway, J. C., Weeks, R. A., Raymon, L. P., Walls, H. C., and Hearn, W. L. (1997). A positive thc urinalysis from hemp (Cannabis) seed oil. J. Anal. Toxicol. 21, 319–320. doi: 10.1093/jat/21.4.319
PubMed Abstract | CrossRef Full Text | Google Scholar

6. Calvi, L., Pentimalli, D., Panseri, S., Giupponi, L., Gelmini, F., Beretta, G., et al. (2018). Comprehensive quality evaluation of medical Cannabis sativa L. Inflorescence and macerated oils based on HS-SPME coupled to GC–MS and LC-HRMS (q-exactive orbitrap®) approach. J. Phar. Biomed. Anal. 150, 208–219. doi: 10.1016/j.jpba.2017.11.073
PubMed Abstract | CrossRef Full Text | Google Scholar

7. Citti, C., Battisti, U. M., Braghiroli, D., Ciccarella, G., Schmid, M., Vandelli, M. A., et al. (2018a). A metabolomic approach applied to a liquid chromatography coupled to high-resolution tandem mass spectrometry method (HPLC-ESI-HRMS/MS): towards the comprehensive evaluation of the chemical composition of cannabis medicinal extracts. Phytochem. Anal. 29, 144–155. doi: 10.1002/pca.2722
PubMed Abstract | CrossRef Full Text | Google Scholar

8. Citti, C., Braghiroli, D., Vandelli, M. A., and Cannazza, G. (2018b). Pharmaceutical and biomedical analysis of cannabinoids: a critical review. J. Pharm. Biomed. Anal. 147, 565–579. doi: 10.1016/j.jpba.2017.06.003
PubMed Abstract | CrossRef Full Text | Google Scholar

9. Citti, C., Pacchetti, B., Vandelli, M. A., Forni, F., and Cannazza, G. (2018c). Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). J. Pharm. Biomed. Anal. 149, 532–540. doi: 10.1016/j.jpba.2017.11.044
PubMed Abstract | CrossRef Full Text | Google Scholar

10. Citti, C., Palazzoli, F., Licata, M., Vilella, A., Leo, G., Zoli, M., et al. (2018d). Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol. J. Pharm. Biomed. Anal. 161, 1–11. doi: 10.1016/j.jpba.2018.08.021
PubMed Abstract | CrossRef Full Text | Google Scholar

11. Citti, C., Battisti, U. M., Ciccarella, G., Maiorano, V., Gigli, G., Abbate, S., et al. (2016a). Analytical and preparative enantioseparation and main chiroptical properties of Iridium(III) bis(4,6-difluorophenylpyridinato)picolinato. J. Chromatogr. A 1467, 335–346. doi: 10.1016/j.chroma.2016.05.059
PubMed Abstract | CrossRef Full Text | Google Scholar

12. Citti, C., Ciccarella, G., Braghiroli, D., Parenti, C., Vandelli, M. A., and Cannazza, G. (2016b). Medicinal cannabis: principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. J. Pharm. Biomed. Anal. 128, 201–209. doi: 10.1016/j.jpba.2016.05.033
PubMed Abstract | CrossRef Full Text | Google Scholar

13. Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., and Colleoni, M. (2007). The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur. J. Pharm. 556, 75–83. doi: 10.1016/j.ejphar.2006.11.006
PubMed Abstract | CrossRef Full Text | Google Scholar

14. Crescente, G., Piccolella, S., Esposito, A., Scognamiglio, M., Fiorentino, A., and Pacifico, S. (2018). Chemical composition and nutraceutical properties of hempseed: an ancient food with actual functional value. Phytochem. Rev. 17, 733–749. doi: 10.1007/s11101-018-9556-2
CrossRef Full Text | Google Scholar

15. de Meijer, E. P. M., and Hammond, K. M. (2005). The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plants. Euphytica 145, 189–198. doi: 10.1007/s10681-005-1164-8
CrossRef Full Text | Google Scholar

16. Deiana, S. (2017). “Chapter 99 – Potential Medical Uses of Cannabigerol: A Brief Overview,” in Handbook of Cannabis and Related Pathologies, ed. V. R. Preedy (San Diego, CA: Academic Press), 958–967. doi: 10.1016/B978-0-12-800756-3.00115-0
CrossRef Full Text | Google Scholar

17. Elsohly, M. A., and Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 78, 539–548. doi: 10.1016/j.lfs.2005.09.011
PubMed Abstract | CrossRef Full Text | Google Scholar

18. Food and Agriculture Organization [FAO]/World Health Organization [WHO] (2008). Interim Summary of Conclusions and Dietary Recommendations on Total fat and Fatty Acids. Geneva: WHO.
Google Scholar

19. Galasso, I., Russo, R., Mapelli, S., Ponzoni, E., Brambilla, I. M., Battelli, G., et al. (2016). Variability in seed traits in a collection of Cannabis sativa L. genotypes. Front. Plant Sci. 7:688. doi: 10.3389/fpls.2016.00688
PubMed Abstract | CrossRef Full Text | Google Scholar

20. Giorgi, A., Panseri, S., Mattare, M. S., Andreis, C., Chiesa, L. M. (2013). Secondary metabolites and antioxidant capacities of Waldheimia glabra (Decne.) Regel from Nepal. J. Sci. Food Agric. 93, 1026–1034. doi: 10.1002/jsfa.5839
PubMed Abstract | CrossRef Full Text | Google Scholar

21. Gowda, H., Ivanisevic, J., Johnson, C. H., Kurczy, M. E., Benton, H. P., Rinehart, D., et al. (2014). Interactive XCMS online: simplifying advanced metabolomic data processing and subsequent statistical analyses. Anal. Chem. 86, 6931–6939. doi: 10.1021/ac500734c
PubMed Abstract | CrossRef Full Text | Google Scholar

22. Guillermo, M.-S. (2016). Can you pass the acid test? Critical review and novel therapeutic perspectives of Δ9-tetrahydrocannabinolic acid A. Cannabis Cannabinoid Res. 1, 124–130. doi: 10.1089/can.2016.0008
PubMed Abstract | CrossRef Full Text | Google Scholar

23. Hanuš, L. O., Meyer, S. M., Muñoz, E., Taglialatela-Scafati, O., and Appendino, G. (2016). Phytocannabinoids: a unified critical inventory. Nat. Prod. Rep. 33, 1357–1392. doi: 10.1039/C6NP00074F
PubMed Abstract | CrossRef Full Text | Google Scholar

24. Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., and Mechoulam, R. (2009). Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol. Sci. 30, 515–527. doi: 10.1016/j.tips.2009.07.006
PubMed Abstract | CrossRef Full Text | Google Scholar

25. Jung, J., Meyer, M. R., Maurer, H. H., Neususs, C., Weinmann, W., and Auwarter, V. (2009). Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques. J. Mass Spectrom. 44, 1423–1433. doi: 10.1002/jms.1624
PubMed Abstract | CrossRef Full Text | Google Scholar

26. Karler, R., Cely, W., and Turkanis, S. A. (1973). The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 13, 1527–1531. doi: 10.1016/0024-3205(73)90141-0
CrossRef Full Text | Google Scholar

27. Lachenmeier, D. W., Kroener, L., Musshoff, F., and Madea, B. (2004). Determination of cannabinoids in hemp food products by use of headspace solid-phase microextraction and gas chromatography–mass spectrometry. Anal. Bioanal. Chem. 378, 183–189. doi: 10.1007/s00216-003-2268-4
PubMed Abstract | CrossRef Full Text | Google Scholar

28. Lehmann, T., Sager, F., and Brenneisen, R. (1997). Excretion of cannabinoids in urine after ingestion of cannabis seed oil. J. Anal. Toxicol. 21, 373–375. doi: 10.1093/jat/21.5.373
PubMed Abstract | CrossRef Full Text | Google Scholar

29. Leizer, C., Ribnicky, D., Poulev, A., Dushenkov, S., and Raskin, I. (2000). The composition of hemp seed oil and its potential as an important source of nutrition. J. Nutraceuticals Funct. Med. Foods 2, 35–53. doi: 10.1300/J133v02n04_04
CrossRef Full Text | Google Scholar

30. Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., De Petrocellis, L., et al. (2006). Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J. Pharm. Exp. Ther. 318, 1375–1387. doi: 10.1124/jpet.106.105247
PubMed Abstract | CrossRef Full Text | Google Scholar

31. Mechoulam, R., Parker, L. A., and Gallily, R. (2002). Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharm. 42, 11S–19S. doi: 10.1002/j.1552-4604.2002.tb05998.x
CrossRef Full Text | Google Scholar

32. Morales, P., Hurst, D. P., and Reggio, P. H. (2017). Molecular targets of the phytocannabinoids: a complex picture. Prog. Chem. Organ. Nat. Prod. 103, 103–131. doi: 10.1007/978-3-319-45541-9_4
PubMed Abstract | CrossRef Full Text | Google Scholar

33. Perrotin-Brunel, H., Buijs, W., Spronsen, J. V., Roosmalen, M. J. E. V., Peters, C. J., Verpoorte, R., et al. (2011). Decarboxylation of Δ9-tetrahydrocannabinol: kinetics and molecular modeling. J. Mol. Struct. 987, 67–73. doi: 10.1016/j.molstruc.2010.11.061
CrossRef Full Text | Google Scholar

34. Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., et al. (2017). Cannabidiol: state of the art and new challenges for therapeutic applications. Pharm. Ther. 175, 133–150. doi: 10.1016/j.pharmthera.2017.02.041
PubMed Abstract | CrossRef Full Text | Google Scholar

35. Ross, S. A., Mehmedic, Z., Murphy, T. P., and ElSohly, M. A. (2000). GC-MS analysis of the total Δ9-thc content of both drug- and fiber-type cannabis seeds. J. Anal. Toxicol. 24, 715–717. doi: 10.1093/jat/24.8.715
CrossRef Full Text | Google Scholar

36. Salek, R. M., Steinbeck, C., Viant, M. R., Goodacre, R., and Dunn, W. B. (2013). The role of reporting standards for metabolite annotation and identification in metabolomic studies. GigaScience 2:13. doi: 10.1186/2047-217x-2-13
PubMed Abstract | CrossRef Full Text | Google Scholar

37. Small, E. (2015). Evolution and classification of cannabis sativa (Marijuana, Hemp) in relation to human utilization. Bot. Rev. 81, 189–294. doi: 10.1007/s12229-015 9157-3
CrossRef Full Text | Google Scholar

38. Struempler, R. E., Nelson, G., and Urry, F. M. (1997). A positive cannabinoids workplace drug test following the ingestion of commercially available hemp seed oil. J. Anal. Toxicol. 21, 283–285. doi: 10.1093/jat/21.4.283
PubMed Abstract | CrossRef Full Text | Google Scholar

39. Takeda, S., Himeno, T., Kakizoe, K., Okazaki, H., Okada, T., Watanabe, K., et al. (2017). Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness. J. Nat. Med. 71, 286–291. doi: 10.1007/s11418-016-1030-0

Dr. Amanda O'Conner

References

References
1
1. Berman, P., Futoran, K., Lewitus, G. M., Mukha, D., Benami, M., Shlomi, T., et al. (2018). A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. Sci. Rep. 8:14280. doi: 10.1038/s41598-018-32651-4
PubMed Abstract | CrossRef Full Text | Google Scholar

2. Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., et al. (2013). Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br. J. Pharmacol. 168, 1456–1470. doi: 10.1111/bph.12043
PubMed Abstract | CrossRef Full Text | Google Scholar

3. Bosy, T. Z., and Cole, K. A. (2000). Consumption and quantitation of Δ9-tetrahydrocannabinol in commercially available hemp seed oil products. J. Anal. Toxicol. 24, 562–566. doi: 10.1093/jat/24.7.562
CrossRef Full Text | Google Scholar

4. Callaway, J. C. (2004). Hempseed as a nutritional resource: an overview. Euphytica 140, 65–72. doi: 10.1007/s10681-004-4811-6
PubMed Abstract | CrossRef Full Text | Google Scholar

5. Callaway, J. C., Weeks, R. A., Raymon, L. P., Walls, H. C., and Hearn, W. L. (1997). A positive thc urinalysis from hemp (Cannabis) seed oil. J. Anal. Toxicol. 21, 319–320. doi: 10.1093/jat/21.4.319
PubMed Abstract | CrossRef Full Text | Google Scholar

6. Calvi, L., Pentimalli, D., Panseri, S., Giupponi, L., Gelmini, F., Beretta, G., et al. (2018). Comprehensive quality evaluation of medical Cannabis sativa L. Inflorescence and macerated oils based on HS-SPME coupled to GC–MS and LC-HRMS (q-exactive orbitrap®) approach. J. Phar. Biomed. Anal. 150, 208–219. doi: 10.1016/j.jpba.2017.11.073
PubMed Abstract | CrossRef Full Text | Google Scholar

7. Citti, C., Battisti, U. M., Braghiroli, D., Ciccarella, G., Schmid, M., Vandelli, M. A., et al. (2018a). A metabolomic approach applied to a liquid chromatography coupled to high-resolution tandem mass spectrometry method (HPLC-ESI-HRMS/MS): towards the comprehensive evaluation of the chemical composition of cannabis medicinal extracts. Phytochem. Anal. 29, 144–155. doi: 10.1002/pca.2722
PubMed Abstract | CrossRef Full Text | Google Scholar

8. Citti, C., Braghiroli, D., Vandelli, M. A., and Cannazza, G. (2018b). Pharmaceutical and biomedical analysis of cannabinoids: a critical review. J. Pharm. Biomed. Anal. 147, 565–579. doi: 10.1016/j.jpba.2017.06.003
PubMed Abstract | CrossRef Full Text | Google Scholar

9. Citti, C., Pacchetti, B., Vandelli, M. A., Forni, F., and Cannazza, G. (2018c). Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). J. Pharm. Biomed. Anal. 149, 532–540. doi: 10.1016/j.jpba.2017.11.044
PubMed Abstract | CrossRef Full Text | Google Scholar

10. Citti, C., Palazzoli, F., Licata, M., Vilella, A., Leo, G., Zoli, M., et al. (2018d). Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol. J. Pharm. Biomed. Anal. 161, 1–11. doi: 10.1016/j.jpba.2018.08.021
PubMed Abstract | CrossRef Full Text | Google Scholar

11. Citti, C., Battisti, U. M., Ciccarella, G., Maiorano, V., Gigli, G., Abbate, S., et al. (2016a). Analytical and preparative enantioseparation and main chiroptical properties of Iridium(III) bis(4,6-difluorophenylpyridinato)picolinato. J. Chromatogr. A 1467, 335–346. doi: 10.1016/j.chroma.2016.05.059
PubMed Abstract | CrossRef Full Text | Google Scholar

12. Citti, C., Ciccarella, G., Braghiroli, D., Parenti, C., Vandelli, M. A., and Cannazza, G. (2016b). Medicinal cannabis: principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. J. Pharm. Biomed. Anal. 128, 201–209. doi: 10.1016/j.jpba.2016.05.033
PubMed Abstract | CrossRef Full Text | Google Scholar

13. Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., and Colleoni, M. (2007). The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur. J. Pharm. 556, 75–83. doi: 10.1016/j.ejphar.2006.11.006
PubMed Abstract | CrossRef Full Text | Google Scholar

14. Crescente, G., Piccolella, S., Esposito, A., Scognamiglio, M., Fiorentino, A., and Pacifico, S. (2018). Chemical composition and nutraceutical properties of hempseed: an ancient food with actual functional value. Phytochem. Rev. 17, 733–749. doi: 10.1007/s11101-018-9556-2
CrossRef Full Text | Google Scholar

15. de Meijer, E. P. M., and Hammond, K. M. (2005). The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plants. Euphytica 145, 189–198. doi: 10.1007/s10681-005-1164-8
CrossRef Full Text | Google Scholar

16. Deiana, S. (2017). “Chapter 99 – Potential Medical Uses of Cannabigerol: A Brief Overview,” in Handbook of Cannabis and Related Pathologies, ed. V. R. Preedy (San Diego, CA: Academic Press), 958–967. doi: 10.1016/B978-0-12-800756-3.00115-0
CrossRef Full Text | Google Scholar

17. Elsohly, M. A., and Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 78, 539–548. doi: 10.1016/j.lfs.2005.09.011
PubMed Abstract | CrossRef Full Text | Google Scholar

18. Food and Agriculture Organization [FAO]/World Health Organization [WHO] (2008). Interim Summary of Conclusions and Dietary Recommendations on Total fat and Fatty Acids. Geneva: WHO.
Google Scholar

19. Galasso, I., Russo, R., Mapelli, S., Ponzoni, E., Brambilla, I. M., Battelli, G., et al. (2016). Variability in seed traits in a collection of Cannabis sativa L. genotypes. Front. Plant Sci. 7:688. doi: 10.3389/fpls.2016.00688
PubMed Abstract | CrossRef Full Text | Google Scholar

20. Giorgi, A., Panseri, S., Mattare, M. S., Andreis, C., Chiesa, L. M. (2013). Secondary metabolites and antioxidant capacities of Waldheimia glabra (Decne.) Regel from Nepal. J. Sci. Food Agric. 93, 1026–1034. doi: 10.1002/jsfa.5839
PubMed Abstract | CrossRef Full Text | Google Scholar

21. Gowda, H., Ivanisevic, J., Johnson, C. H., Kurczy, M. E., Benton, H. P., Rinehart, D., et al. (2014). Interactive XCMS online: simplifying advanced metabolomic data processing and subsequent statistical analyses. Anal. Chem. 86, 6931–6939. doi: 10.1021/ac500734c
PubMed Abstract | CrossRef Full Text | Google Scholar

22. Guillermo, M.-S. (2016). Can you pass the acid test? Critical review and novel therapeutic perspectives of Δ9-tetrahydrocannabinolic acid A. Cannabis Cannabinoid Res. 1, 124–130. doi: 10.1089/can.2016.0008
PubMed Abstract | CrossRef Full Text | Google Scholar

23. Hanuš, L. O., Meyer, S. M., Muñoz, E., Taglialatela-Scafati, O., and Appendino, G. (2016). Phytocannabinoids: a unified critical inventory. Nat. Prod. Rep. 33, 1357–1392. doi: 10.1039/C6NP00074F
PubMed Abstract | CrossRef Full Text | Google Scholar

24. Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., and Mechoulam, R. (2009). Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol. Sci. 30, 515–527. doi: 10.1016/j.tips.2009.07.006
PubMed Abstract | CrossRef Full Text | Google Scholar

25. Jung, J., Meyer, M. R., Maurer, H. H., Neususs, C., Weinmann, W., and Auwarter, V. (2009). Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques. J. Mass Spectrom. 44, 1423–1433. doi: 10.1002/jms.1624
PubMed Abstract | CrossRef Full Text | Google Scholar

26. Karler, R., Cely, W., and Turkanis, S. A. (1973). The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 13, 1527–1531. doi: 10.1016/0024-3205(73)90141-0
CrossRef Full Text | Google Scholar

27. Lachenmeier, D. W., Kroener, L., Musshoff, F., and Madea, B. (2004). Determination of cannabinoids in hemp food products by use of headspace solid-phase microextraction and gas chromatography–mass spectrometry. Anal. Bioanal. Chem. 378, 183–189. doi: 10.1007/s00216-003-2268-4
PubMed Abstract | CrossRef Full Text | Google Scholar

28. Lehmann, T., Sager, F., and Brenneisen, R. (1997). Excretion of cannabinoids in urine after ingestion of cannabis seed oil. J. Anal. Toxicol. 21, 373–375. doi: 10.1093/jat/21.5.373
PubMed Abstract | CrossRef Full Text | Google Scholar

29. Leizer, C., Ribnicky, D., Poulev, A., Dushenkov, S., and Raskin, I. (2000). The composition of hemp seed oil and its potential as an important source of nutrition. J. Nutraceuticals Funct. Med. Foods 2, 35–53. doi: 10.1300/J133v02n04_04
CrossRef Full Text | Google Scholar

30. Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., De Petrocellis, L., et al. (2006). Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J. Pharm. Exp. Ther. 318, 1375–1387. doi: 10.1124/jpet.106.105247
PubMed Abstract | CrossRef Full Text | Google Scholar

31. Mechoulam, R., Parker, L. A., and Gallily, R. (2002). Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharm. 42, 11S–19S. doi: 10.1002/j.1552-4604.2002.tb05998.x
CrossRef Full Text | Google Scholar

32. Morales, P., Hurst, D. P., and Reggio, P. H. (2017). Molecular targets of the phytocannabinoids: a complex picture. Prog. Chem. Organ. Nat. Prod. 103, 103–131. doi: 10.1007/978-3-319-45541-9_4
PubMed Abstract | CrossRef Full Text | Google Scholar

33. Perrotin-Brunel, H., Buijs, W., Spronsen, J. V., Roosmalen, M. J. E. V., Peters, C. J., Verpoorte, R., et al. (2011). Decarboxylation of Δ9-tetrahydrocannabinol: kinetics and molecular modeling. J. Mol. Struct. 987, 67–73. doi: 10.1016/j.molstruc.2010.11.061
CrossRef Full Text | Google Scholar

34. Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., et al. (2017). Cannabidiol: state of the art and new challenges for therapeutic applications. Pharm. Ther. 175, 133–150. doi: 10.1016/j.pharmthera.2017.02.041
PubMed Abstract | CrossRef Full Text | Google Scholar

35. Ross, S. A., Mehmedic, Z., Murphy, T. P., and ElSohly, M. A. (2000). GC-MS analysis of the total Δ9-thc content of both drug- and fiber-type cannabis seeds. J. Anal. Toxicol. 24, 715–717. doi: 10.1093/jat/24.8.715
CrossRef Full Text | Google Scholar

36. Salek, R. M., Steinbeck, C., Viant, M. R., Goodacre, R., and Dunn, W. B. (2013). The role of reporting standards for metabolite annotation and identification in metabolomic studies. GigaScience 2:13. doi: 10.1186/2047-217x-2-13
PubMed Abstract | CrossRef Full Text | Google Scholar

37. Small, E. (2015). Evolution and classification of cannabis sativa (Marijuana, Hemp) in relation to human utilization. Bot. Rev. 81, 189–294. doi: 10.1007/s12229-015 9157-3
CrossRef Full Text | Google Scholar

38. Struempler, R. E., Nelson, G., and Urry, F. M. (1997). A positive cannabinoids workplace drug test following the ingestion of commercially available hemp seed oil. J. Anal. Toxicol. 21, 283–285. doi: 10.1093/jat/21.4.283
PubMed Abstract | CrossRef Full Text | Google Scholar

39. Takeda, S., Himeno, T., Kakizoe, K., Okazaki, H., Okada, T., Watanabe, K., et al. (2017). Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness. J. Nat. Med. 71, 286–291. doi: 10.1007/s11418-016-1030-0

Leave a Comment